A community for China's biotech and pharmaceutical industries.

The biotech and pharmaceutical industries are taking priority in China. Recent changes to safety regulations and a general reorganization have increased BioChina’s productivity and influence in the life sciences. With a large scientific community, BioChina has appealed to foreign biotech companies, which now have a strong presence within the country and in the global market. China’s strong economy and dedication to the life sciences is expected to contribute to a thriving biotech industry now and in the future.

Sponsor
Pfizer


Hotbed News
Resverlogix Corporation (RVX.TO), Shenzhen Hepalink Pharma Strike Deal Worth $450 Million+ Monday, April 27, 2015
First Experiment "Editing" Human Embryos Ignites Ethical Furor Friday, April 24, 2015
Macro-Union Pharma Accused Of Animal Abuse For Hanging Cat Carcasses Thursday, April 16, 2015
Shanghai Haohai Biological To Stage $305 Million IPO In Hong Kong Wednesday, April 22, 2015
Silicon Valley's Cellular Biomedicine Group (CBMG) Expands in Beijing With New Facility and Plans to Hire Wednesday, April 22, 2015
iPhone Manufacturer Foxconn Expects Med Device Biz to Ramp Up From $20 Million to $200 Million By 2020 Thursday, April 23, 2015
Cancer Surge In China Prompts Rise Of Special Patient Hotels Monday, April 13, 2015
Uni-Bio Files For China Approval Of Novel Osteoporosis Drug Friday, April 24, 2015
Sucampo (SCMP) Looks to Add to "Scientific Core" As Global Reach Grows, Says HR Tuesday, April 21, 2015
8 Things That are Hurting Your Resume Thursday, April 16, 2015
12345678910